India Inc India Inc: Friday, 12 January 2018 05:07

Hilleman Labs partners with UK college hub

New Delhi based Hilleman Laboratories plans to collaborate with Imperial College London, Engineering and Physical Sciences Research Council (UK) and other premier international bodies towards low-cost vaccine manufacturing.

Hilleman Laboratories, an equal joint-venture partnership between MSD and Wellcome Trust, is one of the key partners of the new Future Vaccine Manufacturing Hub led by Imperial College London. The hub has been established to increase immunisation coverage across the globe and improve the response to disease outbreaks through the rapid and cost-effective deployment of vaccines. £10 million of funding has been granted by the UK Department for Health, and will be managed by the Engineering and Physical Sciences Research Council (EPSRC).

The hub will collaborate with the Developing Countries Vaccine Manufacturing Network on manufacturing projects in India, Vietnam, Bangladesh, Uganda and China. Integrated approaches that will be explored by researchers at the Hub include the development of synthetic RNA vaccines which can be rapidly manufactured; the rapid production of yeast and bacterially-expressed particles that mimic components of pathogenic viruses and bacteria; and protein stabilisation to preserve vaccines at high temperatures, avoiding the need for refrigerated distribution and storage.

'India Global Business’ has in-depth coverage on related topics.

Login to post comment
Get in Touch
This email address is being protected from spambots. You need JavaScript enabled to view it.

Array ( [format] => html [Itemid] => 148 [option] => com_k2 [view] => item [task] => 7039:hilleman-labs-partners-with-uk-college-hub [id] => 7039:hilleman-labs-partners-with-uk-college-hub )